NPPA computed the Retail Price of Telmisartan I.P. 40 mg + Chlorthalidone IP 6.25 mg + Metoprolol Succinate I.P. 23.75 mg eq. to Metoprolol Tartrate 25 mg (As extended-release form) for M/s Ravenbhel Healthcare Pvt. Ltd. (Manufacturer) & M/s. Alembic Pharmaceuticals Ltd. (Marketer)

Mar 21, 2025 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on March 19, 2025, issued the Computation of Retail Price of Telmisartan I.P. 40 mg + Chlorthalidone IP 6.25 mg + Metoprolol Succinate I.P. 23.75 mg eq. to Metoprolol Tartrate 25 mg (As extended-release form) for M/s Ravenbhel Healthcare Pvt. Ltd. (Manufacturer) & M/s. Alembic Pharmaceuticals Ltd. (Marketer)

The following has been stated namely: -

• The Retail Price has been computed based on the data from July, 2024

• The Retail Price has been computed for Each Film Coated Tablet Containing Telmisartan I.P. 40 mg + Chlorthalidone IP 6.25 mg + Metoprolol Succinate I.P. 23.75 mg eq. to Metoprolol Tartrate 25 mg (As extended-release form) for M/s Ravenbhel Healthcare Pvt. Ltd. (Manufacturer) & M/s. Alembic Pharmaceuticals Ltd. (Marketer)

• The Total MAT is 7,63,68,719

[Notification No. 19(4515)/2025/DP/NPPA/Div.II]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT